Prosecution Insights
Last updated: October 02, 2026
Application No. 17/398,996

APPLICATION OF DEEP LEARNING FOR INFERRING PROBABILITY DISTRIBUTION WITH LIMITED OBSERVATIONS

Final Rejection §101§103
Filed
Aug 10, 2021
Examiner
PLAYER, ROBERT AUSTIN
Art Unit
1686
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
International Business Machines Corporation
OA Round
4 (Final)
14%
Grant Probability
At Risk
5-6
OA Rounds
0m
Est. Remaining
48%
With Interview

Examiner Intelligence

Grants only 14% of cases
14%
Career Allowance Rate
3 granted / 21 resolved
-45.7% vs TC avg
Strong +34% interview lift
Without
With
+33.8%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
35 currently pending
Career history
55
Total Applications
across all art units

Statute-Specific Performance

§101
29.8%
-10.2% vs TC avg
§103
34.8%
-5.2% vs TC avg
§102
3.4%
-36.6% vs TC avg
§112
19.3%
-20.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 21 resolved cases

Office Action

§101 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Applicant's response filed 5/26/2026 has been fully considered. The following rejections and/or objections are either reiterated or newly applied. Status of Claims Claims 1-3, 5-8, 21-23, 25-29, and 34-38 pending and examined on the merits. Claims 4, 9-20, 24 and 30-33 canceled. Claims 36-38 newly added. Priority The instant application claims no benefit of priority. Thus, the effective filing date of the claims is 8/10/2021. The applicant is reminded that amendments to the claims and specification must comply with 35 U.S.C. § 120 and 37 C.F.R. § 1.121 to maintain priority to an earlier-filed application. Claim amendments may impact the effective filing date if new subject matter is introduced that lacks support in the originally filed disclosure. If an amendment adds limitations that were not adequately described in the parent application, the claim may no longer be entitled to the priority date of the earlier filing. Information Disclosure Statement The IDS filed on 17 June 2021 has been entered and considered. A signed copy of the corresponding 1449 form has been included with this Office action. Withdrawn Rejections 35 USC § 112(b) The rejection of claim 35 under 35 USC 112(b) withdrawn in view of Applicant's claim amendments and remarks filed on 5/26/2026. 35 USC § 101 The rejection of claims 4, 24, and 33 under 35 USC 101 withdrawn in view of Applicant's claim cancellations filed on 5/26/2026. 35 USC § 103 The rejection of claims 4, 24, and 33 under 35 USC 103 withdrawn in view of Applicant's claim cancellations filed on 5/26/2026. The rejection of claims 1-34 under 35 USC 103 withdrawn in view of Applicant's claim amendments filed on 5/26/2026 which necessitated new grounds of rejection. Claim Rejections - 35 USC § 101 35 U.S.C. 101 reads as follows: Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title. The rejection of claims 1-3, 5-8, 21-23, 25-29, and 34-35 under 35 U.S.C. 101 are previously recited, and the rejection of claims 36-38 are newly recited necessitated by them being newly added claims. Examiner notes that claims 36-38 correspond to previously recited dependent claims 8, 34, and a combination of claims 2 and 35, respectively. Claims 1-3, 5-8, 21-23, 25-29, and 34-38 are rejected under 35 U.S.C. 101 because the claimed invention is directed to an abstract idea of a mental process, a mathematical concept, organizing human activity, or a law of nature or natural phenomenon without significantly more. In accordance with MPEP § 2106, claims found to recite statutory subject matter (a process, Step 1: YES) are then analyzed to determine if the claims recite any concepts that equate to an abstract idea, law of nature or natural phenomenon (Step 2A, Prong 1). In the instant application, the claims recite the following limitations that equate to an abstract idea: Claims 1, 21, and 29: “generating a limited data set consisting of 1-10 phenotypic output observations through experimentation and/or simulation of the input parameter data set, wherein the data set and the limited data set together form a set of training data for supervised training for a model to train the model to predict a new probability distribution curve of output observations in response to receiving a new set of input parameters, the new probability distribution curve representing a continuous variable that shows a respective probability for all values within a given range” provides a mathematical calculation (the recited step further limits the phenotypic output to be a probability distribution curve which requires mathematical calculations to generate) that is considered a mathematical concept, which is an abstract idea. “training, by using the set of training data, the recurrent neural network by minimizing the loss function with respect to the limited data set of the output observations and with the input parameter data set in the supervised training to form a trained network” provides a mathematical calculation (minimizing a loss function involves selecting and using a mathematical expression, the negative log-likelihood expression in this case) that is considered a mathematical concept, which is an abstract idea. “…produces, as output, a new predicted probability distribution curve of a biological phenotype associated with the biological system, wherein the biological phenotype is exhibited as a continuous variable that shows a respective probability for all values within a given range” provides a mathematical calculation (analyzing a condition to predict a probability distribution for the phenotype requires mathematical calculations) that is considered a mathematical concept, which is an abstract idea. Claims 5 and 25: “the biological system is intrinsically noisy and the trained loss function calculates whether readings outside of a mean range of the input parameter data set are inherent to the biological system or outlier readings” provides mathematical calculations (calculating whether readings are inside or outside a range) that are considered a mathematical concept, which is an abstract idea. These recitations are similar to the concepts of collecting information, analyzing it, and displaying certain results of the collection and analysis in Electric Power Group, LLC, v. Alstom (830 F.3d 1350, 119 USPQ2d 1739 (Fed. Cir. 2016)), organizing and manipulating information through mathematical correlations in Digitech Image Techs., LLC v Electronics for Imaging, Inc. (758 F.3d 1344, 111 U.S.P.Q.2d 1717 (Fed. Cir. 2014)) and comparing information regarding a sample or test to a control or target data in Univ. of Utah Research Found. v. Ambry Genetics Corp. (774 F.3d 755, 113 U.S.P.Q.2d 1241 (Fed. Cir. 2014)) and Association for Molecular Pathology v. USPTO (689 F.3d 1303, 103 U.S.P.Q.2d 1681 (Fed. Cir. 2012)) that the courts have identified as concepts that can be practically performed in the human mind or are mathematical relationships. Therefore, these limitations fall under the “Mental process” and “Mathematical concepts” groupings of abstract ideas. Additionally, while claims 21-29 recite performing some aspects of the analysis on “A computer program product comprising: one or more computer-readable storage media; and program instructions stored on the one or more computer-readable storage media to perform operations” (claim 21) and “A computer system comprising: a processor set; one or more computer-readable storage media; and program instructions stored on the one or more computer-readable storage media to cause the processor set to perform operations” (claim 29), there are no additional limitations that indicate that this requires anything other than carrying out the recited mental processes or mathematical concepts in a generic computer environment. Merely reciting that a mental process is being performed in a generic computer environment does not preclude the steps from being performed practically in the human mind or with pen and paper as claimed. If a claim limitation, under its broadest reasonable interpretation, covers performance of the limitation in the mind but for the recitation of generic computer components, then it falls within the “Mental processes” grouping of abstract ideas. As such, claims 1-8, 21-29, and 33-35 recite an abstract idea (Step 2A, Prong 1: YES). Claims found to recite a judicial exception under Step 2A, Prong 1 are then further analyzed to determine if the claims as a whole integrate the recited judicial exception into a practical application or not (Step 2A, Prong 2). The judicial exceptions listed above are not integrated into a practical application because the claims do not recite an additional element or elements that reflects an improvement to technology. Specifically, the claims recite the following additional elements: Claims 1, 21, and 29: “gathering a data set comprising at least 3000 input parameters for a biological system” provides insignificant extra-solution activities (gathering and generating data through experimentation or simulation are a pre-solution activities involving data gathering steps) that do not serve to integrate the judicial exceptions into a practical application. “building a deep learning neural network comprising a recurrent neural network and a loss function that is a negative log-likelihood function” provides insignificant extra-solution activities (building a NN model is a pre-solution activity involving data gathering and manipulation steps) that do not serve to integrate the judicial exceptions into a practical application. “the trained network” is generally linking the abstract idea identified in claim 1 to the technological environment of neural networks. Claim 21: “A computer program product comprising: one or more computer-readable storage media; and program instructions stored on the one or more computer-readable storage media to perform operations” provides insignificant extra-solution activities (running instructions on generic computer components) that do not serve to integrate the judicial exceptions into a practical application. Claim 29: “A computer system comprising: a processor set; one or more computer-readable storage media; and program instructions stored on the one or more computer-readable storage media to cause the processor set to perform operations” provides insignificant extra-solution activities (running instructions on generic computer components) that do not serve to integrate the judicial exceptions into a practical application. The steps for gathering, generating, inputting, and outputting data, and building a model are insignificant extra-solution activities that do not serve to integrate the recited judicial exceptions into a practical application because they are pre- and post-solution activities involving data gathering, data manipulation, and sample manipulation steps (see MPEP 2106.04(d)(2)). Furthermore, the limitations regarding implementing program instructions do not indicate that they require anything other than mere instructions to implement the abstract idea in a generic way or in a generic computing environment. As such, this limitation equates to mere instructions to implement the abstract idea on a generic computer that the courts have stated does not render an abstract idea eligible in Alice Corp., 573 U.S. at 223, 110 USPQ2d at 1983. See also 573 U.S. at 224, 110 USPQ2d at 1984. Therefore, claims 1-8, 21-29, and 33-35 are directed to an abstract idea (Step 2A, Prong 2: NO). Claims found to be directed to a judicial exception are then further evaluated to determine if the claims recite an inventive concept that provides significantly more than the judicial exception itself (Step 2B). The claims do not include additional elements that are sufficient to amount to significantly more than the judicial exception because the claims recite additional elements that are insignificant extra-solution activities that do not serve to integrate the recited judicial exceptions into a practical application, or equate to mere instructions to apply the recited exception in a generic way or in a generic computing environment. As discussed above, there are no additional elements to indicate that the claimed “A computer program product comprising: one or more computer-readable storage media; and program instructions stored on the one or more computer-readable storage media to perform operations” (claim 21) and “A computer system comprising: a processor set; one or more computer-readable storage media; and program instructions stored on the one or more computer-readable storage media to cause the processor set to perform operations” (claim 29), requires anything other than generic computer components in order to carry out the recited abstract idea in the claims. Claims that amount to nothing more than an instruction to apply the abstract idea using a generic computer do not render an abstract idea eligible. MPEP 2106.05(f) discloses that mere instructions to apply the judicial exception cannot provide an inventive concept to the claims. Use of a computer or other machinery in its ordinary capacity for economic or other tasks (e.g., to receive, store, or transmit data) or simply adding a general-purpose computer or computer components after the fact to an abstract idea (e.g., a fundamental economic practice or mathematical equation) does not integrate a judicial exception into a practical application or provide significantly more. See Affinity Labs v. DirecTV, 838 F.3d 1253, 1262, 120 USPQ2d 1201, 1207 (Fed. Cir. 2016) (cellular telephone); TLI Communications LLC v. AV Auto, LLC, 823 F.3d 607, 613, 118 USPQ2d 1744, 1748 (Fed. Cir. 2016) (computer server and telephone unit). Additionally, the limitations for gathering, generating, inputting, and outputting data, and building a model are insignificant extra-solution activities that do not serve to integrate the recited judicial exceptions into a practical application. Furthermore, no inventive concept is claimed by these limitations as they are well-understood, routine, and conventional. The additional elements do not comprise an inventive concept when considered individually or as an ordered combination that transforms the claimed judicial exception into a patent-eligible application of the judicial exception. Therefore, the claims do not amount to significantly more than the judicial exception itself (Step 2B: No). As such, claims 1-8, 21-29, and 33-35 are not patent eligible. Response to Arguments under 35 USC § 101 Applicant’s arguments filed 5/26/2026 are fully considered but they are not persuasive. Applicant asserts, regarding independent claims 1, 21, and 29, that the "amendments further clarify that the method is integrated into a practical application" because "[t]he recited method of amended claim 1 achieves improvements in a technical field" which "reduce[s] the time and computational cost for simulations and experiments required to predict biological objectives and optimize synthetic design" because the "technical details about the character of the output of the trained network, namely that the network predicts a predicted probability distribution curve for a continuous variable and that the curve shows a respective probability for all values within a given range", and therefore "amended claim 1 is patent-eligible under Step 2A, prong two" (Remarks 5/26/2026 pages 2-6). Examiner notes that the clarifying amendments to the independent claims are not considered additional elements, and even if they were to be considered additional elements, they would not provide a specific technical improvement that might integrate the identified judicial exception of a mathematical calculation into a practical application. Provided below is an excerpt from MPEP 2106.04(d).I which lists the following example considerations for evaluating whether a judicial exception is integrated into a practical application: An improvement in the functioning of a computer or an improvement to other technology or another technical field, as discussed in MPEP §§ 2106.04(d)(1) and 2106.05(a); Applying or using a judicial exception to effect a particular treatment or prophylaxis for a disease or medical condition, as discussed in MPEP § 2106.04(d)(2); Implementing a judicial exception with, or using a judicial exception in conjunction with, a particular machine or manufacture that is integral to the claim, as discussed in MPEP § 2106.05(b); Effecting a transformation or reduction of a particular article to a different state or thing, as discussed in MPEP § 2106.05(c); and Applying or using the judicial exception in some other meaningful way beyond generally linking the use of the judicial exception to a particular technological environment, such that the claim as a whole is more than a drafting effort designed to monopolize the exception, as discussed in MPEP § 2106.05(e). As such, there are no additional elements that would serve to improve the function of a computer or an improvement to other technology or another technical field. Examiner also notes MPEP 2106.05(a) II: it is important to keep in mind that an improvement in the abstract idea itself (e.g. a recited fundamental economic concept) is not an improvement in technology. Applicant also asserts that the Ex parte Desjardins decision is applicable to the instant application because "[t]he Desjardins claim was also related to training a machine learning model" and that the decision "said that for Examiners and Board to 'essentially [equate] any machine learning with an unpatentable 'algorithm' and the remaining additional elements as 'generic computer components' without adequate explanation' was an error" (Remarks 5/26/2026 page 6). Examiner notes above in the section "Claim Rejections - 35 USC 101" that only the additional elements in the preambles of claims 21 and 29 are identified as generic computer components, and other additional elements such as gathering, generating, inputting, and outputting data, and building a model are insignificant extra-solution activities that do not serve to integrate the recited judicial exceptions into a practical application. Therefore, the decision in the Ex parte Desjardins case is not applicable to the instant application. Therefore, the rejection of claims 1, 21, and 29 under 35 USC 101 is maintained. All other claims depend from these independent claims; therefore, their rejection is likewise maintained. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The rejection of claims 1-3, 5-8, 21-23, 25-29, and 34-35 under 35 USC 103 contains newly recited portions necessitated by claim amendments, and the rejection of claims 36-38 are newly recited necessitated by them being newly added claims. Examiner notes that claims 36-38 correspond to previously recite dependent claims 8, 34, and a combination of claims 2 and 35, respectively. With these newly recited portions, Examiner is not conceding that the amendments to the claims are not taught by the previously cited prior art references. Claims 1, 3, 5, 21, 23, 25, 29, 34, and 37 rejected under 35 U.S.C. 103 as being unpatentable over Rolfe et al. (US-20190244680) in view of Cope et al. (US-20140214391) and Rabinowitz (US-20160371432). Regarding claims 1, 21, and 29, Rolfe teaches gathering a data set comprising at least 3000 input parameters for a biological system (Para.0068 "The transcriptome can be used to analyze genes that are differentially expressed based upon the phenotype of the organism", as there are thousands of genes measured in a transcriptome, each representing an input parameter). Rolfe also teaches building a deep learning neural network comprising a recurrent neural network and a loss function that is a negative log-likelihood function (Para.0034 "A conditional likelihood p(x|z) can be selected to be a product of independent Gaussian distributions with means and variances defined by a neural network applied to a latent representation z" and para.0097 "Existing approaches such as those described above can use a negative binomial distribution instead of a Poisson distribution"). Rolfe also teaches training, by using the set of training data, the recurrent neural network by minimizing the loss function with respect to the limited data set of the output observations and with the input parameter data set in the supervised training to form a trained network, wherein the minimizing of the loss function maximizes a probability that the 1-10 phenotypic output observations are within a predicted probability distribution of the recurrent neural network (Para.0032 "Denoting the observed data by x and the latent variables by z, variational autoencoders are generative models p(x, z) paired with variational approximations to the posterior probability distribution of the latent variables q(z|x), trained by maximizing the evidence lower bound (ELBO) on the log-likelihood"). Rolfe also teaches inputting a condition about the biological system into the trained network such that, in response, the trained network produces, as output, a new predicted probability distribution of a biological phenotype associated with the biological system (Abstract "ML may realize an efficient estimation of multi-disease genetic and environmental correlation matrices", para.0179 "the present disclosure may be applied to plants to facilitate plant breeding by isolating genetic causes of particular phenotypes or to predict which offspring (from the space of all possible offspring produced by pairs of plants in the dataset) would produce desired phenotypes across environments and/or in a given environment" implies inputting a desired phenotype to produce gene expression distributions for that input phenotype, and para.0107 "One use of the technology described in the present application is to test whether expression of a single gene can behave differently depending on disease condition"). Rolfe also teaches the 1-10 phenotypic output observations are discrete variables, the trained network predicts respective probability distribution values for all possible discrete numbers, and the trained network comprises one or more additional neural network layers to ensure that a sum of the predicted probability distribution values for an input condition equals one (claim 21) (Para.0201 "This approach is possible whenever the approximating posteriors for each hidden variable, q.sub.i(z.sub.i|x, ϕ), are independent given x and ϕ; the cumulative distribution function (CDF) of each q.sub.i is invertible; and the inverse CDF each q.sub.i, is differentiable. Specifically, choose [D] to be the uniform distribution between 0 and 1, and ƒ.sub.i to be the inverse CDF of q.sub.i"). Rolfe does not explicitly teach: generating a limited data set consisting of 1-10 phenotypic output observations through experimentation and/or simulation of the input parameter data set, wherein the data set and the limited data set together form a set of training data for supervised training for a model to train the model to predict a new probability distribution curve of output observations in response to receiving a new set of input parameters; producing a trained network that produces an output of a new probability distribution curve representing a continuous variable that shows a respective probability for all values within a given range (claims 1 and 29); nor producing a trained network that produces an output of respective probability for all possible integers within a training range wherein the respective probability distribution includes values for all possible integers within a range for the biological system (claim 21). However, Cope teaches using a set of observations for building and fitting a model to (Para.0066 ""Training set" refers to a set of sequence-activity data or observations that one or more models are fitted to and built upon. For instance, for a protein sequence-activity model, a training set comprises residue sequences for an initial or improved protein variant library. Typically, these data include complete or partial residue sequence information, together with an activity value for each protein in the library. In some cases, multiple types of activities (e.g., rate constant data and thermal stability data) are provided together in the training set. The activity is sometimes a beneficial property"). Coupled with the k-fold cross-validation of Rolfe teach the full limitation (Para.0044 "The quality of a model relative to conventional approaches can be assessed using an k-fold cross-validation of the log-likelihood. In k-fold cross-validation, a sample is randomly partitioned into k equally sized subsamples. Of the k subsamples, one subsample is retained as validation data for testing the model. The remaining (k−1) subsamples can be used as training data. The cross-validation process can be repeated k times, with each of the k subsamples used once as validation data. The k results can then be averaged to provide an estimation of the log-likelihood"). However, Rabinowitz suggests using a continuous probability distribution of a variable to produce probabilities over a specified range of values (para.0112 "Cumulative Distribution Function (CDF) curve may refer to a monotone increasing, right continuous probability distribution of a variable, where the ‘y’ coordinate of a point on the curve refers to the probability that the variable takes on a value less than or equal to the ‘x’ coordinate of the point" and para.0367 "First make discrete the range of X,Y intensity response into T bins B.sup.x,B.sup.Y, derived as T equally spaced percentiles of data on respective channels (T<=20). Then one may estimate P((X,Y)|g) as P((X,Y)|g)˜f(b.sub.x,b.sub.y,g) for Xεb.sub.x,Yεb.sub.y, where f(b.sub.x,b.sub.y,g) is estimated from data"). Rabinowitz also suggests using a probability distribution of a discrete (integer)variable to produce values for over a specified range of values (para.0159 "The main idea behind the algorithm is that for a given positive integer c, the order p.sub.AA|AA.sup.x(c), p.sub.AB|AA.sup.x(c), p.sub.BB|AA.sup.x(c), p.sub.AA|AB.sup.x(c), p.sub.AB|AB.sup.x(c), p.sub.BB|AB.sup.x(c), p.sub.AA|BB.sup.x(c), p.sub.AB|BB.sup.x(c), and p.sub.BB|BB.sup.x(c), will vary based on the chromosome copy number. The same holds for the y-channel. In one embodiment of the present disclosure, one may use this order to determine chromosome copy number"). It would have been obvious to one of ordinary skill in the art to perform the claimed analysis on discrete variables, as such a modification represents a predictable variation of known techniques. Therefore, it would have been obvious to one of ordinary skill in the art as of the effective filing date of the claimed invention to modify the methods of Rolfe as taught by Cope in order to generate a training set for generating a model (para.0067 "The term "observation" is information about protein or other biological entity that may be used in a training set for generating a model such as a sequence activity model. The term "observation" may refer to any sequenced and assayed biological molecules, including protein variants. In certain embodiments, each observation is an activity value and an associated sequence for a variant in a library"). One skilled in the art would have a reasonable expectation of success because both methods are concerned with building neural network models for predicting a phenotype. Therefore, it would have been obvious to one of ordinary skill in the art as of the effective filing date of the claimed invention to modify the methods of Rolfe as taught by Rabinowitz in order to use the output of one model as the input to another (para.0024 "the output from one aspect of the present disclosure may be used as input for, or to help select appropriate input for other aspects of the present disclosure in an iterative process", additionally para.0532 explicitly suggests that "[i]t will be appreciated that several of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or applications. Various presently unforeseen or unanticipated alternatives, modifications, variations, or improvements therein may be subsequently made by those skilled in the art which are also intended to be encompassed by the following claims"). One skilled in the art would have a reasonable expectation of success because both methods are concerned with predicting phenotypes of biological systems. Regarding claims 3 and 23, Rolfe in view of Cope and Rabinowitz teach the methods of Claims 1 and 21 on which this claim depends/these claims depend, respectively. Rolfe also teaches the limited data set consists of 1 phenotypic output observation (Para.0044 "The quality of a model relative to conventional approaches can be assessed using an k-fold cross-validation of the log-likelihood. In k-fold cross-validation, a sample is randomly partitioned into k equally sized subsamples. Of the k subsamples, one subsample is retained as validation data for testing the model. The remaining (k−1) subsamples can be used as training data. The cross-validation process can be repeated k times, with each of the k subsamples used once as validation data. The k results can then be averaged to provide an estimation of the log-likelihood" also encompasses a situation where k=2, leaving a single observation for training data. Furthermore, while this approach has been tried by many others, it generally causes overfitting of the resulting model (i.e. having too many parameters [genes] relative to the number of observations) as evidenced by Cope et al. in para.0089 ""Overfitting" refers to a condition that occurs when a statistical model describes random error or noise instead of the underlying relationship. Overfitting generally occurs when a model is excessively complex, such as having too many parameters relative to the number of observations. A model which has been overfit will generally have poor predictive performance, as it can exaggerate minor fluctuations in the data" (US-20140214391)). Regarding claims 5 and 25, Rolfe in view of Cope and Rabinowitz teach the methods of Claims 1 and 21 on which this claim depends/these claims depend, respectively. Rolfe also teaches the biological system is intrinsically noisy and the trained loss function calculates whether readings outside of the mean range of the input parameter data set are inherent to the biological system or outlier readings (Para.0190 "Unsupervised learning of probabilistic models can facilitate tasks such as denoising to extract a signal from a mixture of signal and noise, and inpainting to reconstruct lost or corrupted parts of an image"). Regarding claims 34 and 37, Rolfe in view of Cope and Rabinowitz teach the methods of Claims 1 and 29 on which this claim depends/these claims depend, respectively. Rolfe also teaches the 1-10 phenotypic output observations are continuous variables, the trained network provides the predicted probability distribution by interpolating discrete observations where a last layer of the trained network is normalized with a normalization factor to ensure that a cumulative trapezoidal numerical integration of the predicted probability distribution equals one (Para.0206 "The approach can run into challenges with discrete distributions, such as, for example, Restricted Boltzmann Machines (RBMs). An approximating posterior that only assigns non-zero probability to a discrete domain corresponds to a CDF that is piecewise-constant. That is, the range of the CDF is a proper subset of the interval [0, 1]. The domain of the inverse CDF is thus also a proper subset of the interval [0, 1] and its derivative is generally not defined"). Claims 2, 22, 35 and 38 rejected under 35 U.S.C. 103 as being unpatentable over Rolfe et al. (US-20190244680) in view of Cope et al. (US-20140214391) and Rabinowitz (US-20160371432) as applied to claims 1, 3, 5, 21, 23, 25, 29, 34, and 37 above, and further in view of Isayev et al. (US-20200168302). Rolfe et al. in view of Cope et al. and Rabinowitz et al. are applied to claims 1, 3, 5, 21, 23, 25, 29, 34, and 37. Regarding claims 2, 22, 35, and 38, Rolfe in view of Cope and Rabinowitz teach the method of Claims 1, 21, and 29 on which this claim depends/these claims depend, respectively. Rolfe, Cope, nor Rabinowitz explicitly teach the deep learning neural network is selected from a recurrent neural network and a long short-term memory network and the loss function is a negative log-likelihood function. However, Isayev teaches the deep learning neural network is selected from a recurrent neural network and a long short-term memory network and the loss function is a negative log-likelihood function (Para.0033 "FIG. 2 illustrates, on the left hand side, the scheme of a generative stack-augmented RNN time step. This model has two modes—training and generating. During training, the input token is a character of the currently processed SMILES string from the training set. The model outputs probability vector [p] of the next character given the prefix. A vector of parameters [theta] is optimized by a cross-entropy loss function minimization.", which reads on the limitation because a RNN is a type of LSTM, and a "cross-entropy" loss function is another name for a negative log-likelihood function). It also would have been obvious to one of ordinary skill in the art to set the claimed maximum edge of the predicted probability distribution, because the biological data the distributions are derived from are finite (i.e. the curves should not go on forever because the modeled system is finite), as such a modification represents a predictable variation of known techniques. Therefore, it would have been obvious to one of ordinary skill in the art as of the effective filing date of the claimed invention to modify the methods of Rolfe and Cope as taught by Isayev in order to use a LSTM network type RNN with a negative log-likelihood function in order to more properly model sequence dependent data types (Isayev, Para. 0031 "Another weakness of regular recurrent neural networks is their inability to capture long term dependencies which leads to difficulties in generalizing to longer sequences. [] Therefore, Stack RNNs are a proper choice for modeling such sequence dependencies."). One skilled in the art would have a reasonable expectation of success because both methods are concerned with building neural network models for predicting desired properties of a biological system. Claims 6-8, 26-28, and 36 rejected under 35 U.S.C. 103 as being unpatentable over Rolfe et al. (US-20190244680) in view of Cope et al. (US-20140214391) and Rabinowitz (US-20160371432) as applied to claims 1, 3, 5, 21, 23, 25, 29, 34, and 37 above, and further in view of Chait et al. (US-20200286580). Rolfe et al. in view of Cope et al. and Rabinowitz et al. are applied to claims 1, 3, 5, 21, 23, 25, 29, 34, and 37. Regarding claims 6 and 26, Rolfe in view of Cope and Rabinowitz teach the method of Claims 1 and 21 on which this claim depends/these claims depend, respectively. Rolfe, Cope, nor Rabinowitz explicitly teach the biological system is selected from the group consisting of a cellular system, a biological collective, a synthetic gene circuit, and combinations thereof. However, Chait teaches the biological system is selected from the group consisting of a cellular system, a biological collective, a synthetic gene circuit, and combinations thereof (Para.0004 "correct functioning of individual units in the context of the whole (synthetic) biomolecular network can be tested and its dynamic functionality assessed even before all parts of the network are implemented" and para.0010 "the output from the simulation provides input into the cellular part of the biological circuit via the controlling means; and cell state or environmental parameter measurements taken from the cell(s) provide input into the simulated part of the circuit"). Therefore, it would have been obvious to one of ordinary skill in the art as of the effective filing date of the claimed invention to modify the methods of Rolfe and Cope as taught by Chait in order to enable faster, cheaper, and better predictions of how a biological unit will perform if used in a larger network (Para.0004 "this enables better predictions of how a unit will perform if it is implemented into a larger network in situ and faster and more economical laboratory development cycle"). One skilled in the art would have a reasonable expectation of success because both methods are concerned with predicting phenotypes of biological systems. Regarding claims 7-8, 27-28 and 36, Rolfe in view of Cope and Rabinowitz teach the method of Claims 1, 21, and 29 on which this claim depends/these claims depend, respectively. Chait also teaches: the input parameters are selected from the group consisting of cell growth rate, cell lysis rate, cell motility, gene expression, nutrient concentration, temperature, pH, activation rate, transcription rate, agar density, and combinations thereof; and the biological phenotype is selected from the group consisting of number of mRNA produced, number of amino acids, number of proteins, cellular growth, cellular adhesion, cellular sensing, fluorescence strength, optical density, chemical concentration, and combinations thereof (Para.0063 "Environmental parameters that may be measured include pH, temperature, light or fluorescence emission or wavelength frequency, oxygen saturation, or the presence or concentration of any secreted or excreted molecules or metabolites as described above."; Para.0061 "In some cases the presence or concentration of one or more metabolites or molecule produced and optionally secreted or excreted by the cells is measured. Such molecules might include nucleic acids, (for example DNA, mRNA, microRNA, and small interfering RNAs), proteins, antibodies, receptors, ligands, signaling molecules, protein complexes and toxins." and para.0062 "Cell state parameters that may be measured include cell growth, cell division, reproduction, rate of cell growth, division, or reproduction, cell number, cell density, cell confluence, viability, respiration, cell morphology, cell shape, cell adhesion, spatial organization of tissues, metabolic condition, cell motility, cell movement, cytoskeletal arrangement, cytoplasmic movement, intracellular trafficking, electrophysiological state, firing times of neurons, degree of differentiation, expression of specific molecules such as ligands or receptors on the cell surface, receptor activation, pH and temperature", as cell lysis rate can be calculated from cell/optical density measurements over time, and transcription rate can be calculated from measurement of mRNA over time). Response to Arguments under 35 USC § 103 Applicant’s arguments filed 5/26/2026 are fully considered but they are not persuasive. Applicant asserts that "Rolfe fails to disclose or suggest producing a trained network that produces an output of a 'new probability distribution curve representing a continuous variable that shows a respective probability for all values within a given range'" for claims 1 and 29 (Remarks 5/25/2026 page 8). Examiner notes above that Rabinowitz teaches or suggests using a continuous probability distribution of a variable to produce probabilities over a specified range of values. Applicant asserts that "Rolfe fails to disclose or suggest producing a trained network that produces an output of 'respective probability for all possible integers within a training range' 'wherein the respective probability distribution includes values for all possible integers within a range for the biological system" for claim 21 (Remarks 5/25/2026 page 9). Examiner notes above that Rabinowitz teaches or suggests using a probability distribution of a discrete (integer)variable to produce values for over a specified range of values. Applicant asserts that the rejection of claim 34 "citing Rolfe is deficient because no explanation is made or showing is provided of how paragraph 0206 of Rolfe discloses a 'cumulative trapezoidal numerical integration'" (Remarks 5/26/2026 page 10). Examiner calls out a specific line of para.0206 here "That is, the range of the CDF is a proper subset of the interval [0, 1]" in order to show that a cumulative distribution function would have an area bound by one. Additionally, it is inherent in the process of generating a CDF that the values are normalized with an asymptotic sum of one. Therefore, the rejection of claims 1, 21, 29, and 34 under 35 USC 103 is maintained. All other claims depend from independent claims 1, 21, or 29; therefore, their rejection is likewise maintained, and the rejection of claims 36-38 are newly made. Conclusion No claims are allowed. Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the TH REE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this finaI action. Inquiries Any inquiry concerning this communication or earlier communications from the examiner should be directed to Robert A. Player whose telephone number is (571)272-6350. The examiner can normally be reached Mon-Fri, 8am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Larry D. Riggs can be reached on 571-270-3062. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /R.A.P./Examiner, Art Unit 1686 /KAITLYN L MINCHELLA/Primary Examiner, Art Unit 1685
Read full office action

Prosecution Timeline

Show 10 earlier events
Jan 21, 2026
Response after Non-Final Action
Jan 28, 2026
Request for Continued Examination
Jan 28, 2026
Examiner Interview Summary
Feb 02, 2026
Response after Non-Final Action
Feb 24, 2026
Non-Final Rejection mailed — §101, §103
May 15, 2026
Interview Requested
May 26, 2026
Response Filed
Aug 25, 2026
Final Rejection mailed — §101, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12734067
EYE HEALTH DATA ANALYSIS USING ARTIFICIAL INTELLIGENCE
5y 5m to grant Granted Sep 15, 2026
Patent 12584180
Methods and Systems for Determining Proportions of Distinct Cell Subsets
1y 0m to grant Granted Mar 24, 2026
Patent 12571054
Methods and Systems for Determining Proportions of Distinct Cell Subsets
1y 0m to grant Granted Mar 10, 2026
Study what changed to get past this examiner. Based on 3 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
14%
Grant Probability
48%
With Interview (+33.8%)
4y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 21 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month